Mutual Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.98M | Sell |
21,407
-765
| -3% | -$107K | 0.06% | 284 |
|
|
2025
Q4 | $2.72M | Sell |
22,172
-806
| -4% | -$98K | 0.06% | 296 |
|
|
2025
Q3 | $2.77M | Buy |
22,978
+1,750
| +8% | +$199K | 0.06% | 286 |
|
|
2025
Q2 | $2.47M | Buy |
21,228
+3,072
| +17% | +$327K | 0.06% | 274 |
|
|
2025
Q1 | $1.87M | Sell |
18,156
-3,917
| -18% | -$404K | 0.05% | 295 |
|
|
2024
Q4 | $2.02M | Sell |
22,073
-1,005
| -4% | -$90.5K | 0.06% | 279 |
|
|
2024
Q3 | $2.05M | Sell |
23,078
-27,538
| -54% | -$2.1M | 0.06% | 272 |
|
|
2024
Q2 | $3.93M | Buy |
50,616
+16,056
| +46% | +$1.07M | 0.12% | 167 |
|
|
2024
Q1 | $2.53M | Buy |
34,560
+6,654
| +24% | +$512K | 0.08% | 225 |
|
|
2023
Q4 | $2.26M | Buy |
27,906
+702
| +3% | +$54.6K | 0.08% | 239 |
|
|
2023
Q3 | $2.04M | Buy |
27,204
+1,064
| +4% | +$81.8K | 0.08% | 237 |
|
|
2023
Q2 | $2.01M | Sell |
26,140
-181
| -0.7% | -$14.4K | 0.08% | 253 |
|
|
2023
Q1 | $2.18M | Buy |
26,321
+1,828
| +7% | +$151K | 0.09% | 225 |
|
|
2022
Q4 | $2.1M | Sell |
24,493
-1,280
| -5% | -$101K | 0.09% | 216 |
|
|
2022
Q3 | $1.59M | Buy |
25,773
+2,304
| +10% | +$145K | 0.08% | 242 |
|
|
2022
Q2 | $1.45M | Buy |
23,469
+2,449
| +12% | +$152K | 0.1% | 248 |
|
|
2022
Q1 | $1.25M | Buy |
21,020
+179
| +0.9% | +$11.4K | 0.07% | 309 |
|
|
2021
Q4 | $1.51M | Buy |
20,841
+1,753
| +9% | +$121K | 0.08% | 281 |
|
|
2021
Q3 | $1.33M | Buy |
19,088
+762
| +4% | +$53.5K | 0.08% | 294 |
|
|
2021
Q2 | $1.26M | Sell |
18,326
-1,819
| -9% | -$121K | 0.07% | 310 |
|
|
2021
Q1 | $1.3M | Sell |
20,145
-6,427
| -24% | -$414K | 0.09% | 272 |
|
|
2020
Q4 | $1.55M | Buy |
26,572
+2,685
| +11% | +$162K | 0.12% | 212 |
|
|
2020
Q3 | $1.51M | Buy |
23,887
+3,446
| +17% | +$239K | 0.13% | 179 |
|
|
2020
Q2 | $1.57M | Buy |
20,441
+4,065
| +25% | +$312K | 0.15% | 156 |
|
|
2020
Q1 | $1.22M | Buy |
16,376
+4,352
| +36% | +$301K | 0.17% | 156 |
|
|
2019
Q4 | $781K | Sell |
12,024
-235
| -2% | -$15.3K | 0.08% | 265 |
|
|
2019
Q3 | $777K | Sell |
12,259
-4,390
| -26% | -$287K | 0.1% | 239 |
|
|
2019
Q2 | $1.13M | Buy |
16,649
+5,876
| +55% | +$387K | 0.15% | 179 |
|
|
2019
Q1 | $700K | Buy |
10,773
+1,535
| +17% | +$102K | 0.1% | 225 |
|
|
2018
Q4 | $578K | Buy |
9,238
+62
| +0.7% | +$4.33K | 0.11% | 215 |
|
|
2018
Q3 | $708K | Sell |
9,176
-1,077
| -11% | -$81.3K | 0.11% | 229 |
|
|
2018
Q2 | $726K | Buy |
10,253
+863
| +9% | +$60.9K | 0.17% | 184 |
|
|
2018
Q1 | $708K | Buy |
+9,390
| New | +$746K | 0.18% | 189 |
|
Other funds holding GILD
VCM
VPM
Mutual Advisors's GILD Position: Q1 2026 in Review
Mutual Advisors reduced its Gilead Sciences (GILD) stake by 3.5% in Q1 2026, selling an estimated $107K and leaving 21,407 shares worth $2.98M. The position accounts for 0.06% of the portfolio, ranked #284.
Mutual Advisors first reported a position in GILD in Q1 2018 and has held it in 33 quarters since. The position peaked at $3.93M in Q2 2024. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Mutual Advisors held 21,407 shares of Gilead Sciences worth $2.98M as of Q1 2026.
- Mutual Advisors sold 765 Gilead Sciences shares in Q1 2026, an estimated $107K.
- Gilead Sciences made up 0.06% of Mutual Advisors's portfolio in Q1 2026, its #284 holding.
- Mutual Advisors first reported a position in Gilead Sciences in Q1 2018 and has held it in 33 quarters since.
- Mutual Advisors's Gilead Sciences position peaked at $3.93M in Q2 2024.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Mutual Advisors's 13F filing for Q1 2026, filed 4 May 2026.